Valérie Méresse

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

Birgit Geoerger, Darren Hargrave, Fabienne Thomas et al. · Neuro-Oncology · 2010 · 159 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

C. Willemien Menke‐van der Houven van Oordt, Carlos Gomez-Roca, Carla van Herpen et al. · Oncotarget · 2016 · 156 citations · Full text

Medicine, Cancer Biology, Oncology +14

Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children.

Valérie Méresse, Olivier Hartmann, Gilles Vassal et al. · PubMed · 1992 · 138 citations

Medicine, Hematology, Oncology +10

Stem Cell Factor in Combination With Filgrastim After Chemotherapy Improves Peripheral Blood Progenitor Cell Yield and Reduces Apheresis Requirements in Multiple Myeloma Patients: A Randomized, Controlled Trial

Thierry Façon, Jean‐Luc Harousseau, Frédéric Maloisel et al. · Blood · 1999 · 100 citations

Medicine, Hematology, Oncology +17

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

Norbert Vey, Jacques Delaunay, Giovanni Martinelli et al. · Oncotarget · 2016 · 99 citations · Full text

Medicine, Hematology, Oncology +15